Sections

Acute Poststreptococcal Glomerulonephritis

Sections Acute Poststreptococcal Glomerulonephritis
Overview
Presentation
DDx
Workup
Treatment
Medication
Questions & Answers
References

Medication

Medication Summary

The need for medicines in acute poststreptococcal glomerulonephritis (ASPGN) is usually limited in scope and in length. Administer antibiotics (penicillin or erythromycin) for 10 days to ensure eradication of the streptococcus if the disease is believed to be acute poststreptococcal glomerulonephritis and if risk of contamination is present. Some clinicians use this treatment only when evidence suggests an active infection.

Antihypertensives are usually not necessary after the child leaves the hospital, although mild hypertension may persist for as many as 6 weeks. The medications that can be used span the entire range of antihypertensives, such as vasodilators (eg, hydralazine), calcium channel-blocking agents (eg, amlodipine), or angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril).

Carefully monitor blood pressure (BP) for at least 1 week after the drug is discontinued to ensure that rebound hypertension does not occur.

Diuretic agents (eg, furosemide) are rarely needed in the long term; hypertension persisting beyond the first week may suggest a diagnosis other than acute glomerulonephritis.

Class Summary

Antihypertensive agents are commonly used during initial phase of acute glomerulonephritis.

Amlodipine (Norvasc)

View full drug information

Amlodipine is generally regarded as a dihydropyridine, although experimental evidence suggests that it may also bind to the nondihydropyridine binding sites.

Amlodipine blocks postexcitation release of calcium ions into cardiac and vascular smooth muscle, thereby inhibiting the activation of ATPase on myofibril contraction. The overall effect is reduced intracellular calcium levels in cardiac and smooth muscle cells of the coronary and peripheral vasculature, resulting in dilatation of the coronary and peripheral arteries. This drug may also potentiate angiotensin-converting enzyme (ACE) inhibitor effects.

During depolarization, amlodipine inhibits calcium ions from entering the slow channels and voltage-sensitive areas of vascular smooth muscle and myocardium, which benefits nonpregnant patients with systolic dysfunction, hypertension, or arrhythmias. This agent a substantially longer half-life than nifedipine and diltiazem and is administered once daily.

Furosemide (Lasix)

View full drug information

Furosemide is a loop diuretic that is useful in patients with acute glomerulonephritis who are edematous. This agent also has some BP-lowering effect by increasing excretion of salt and water via interfering with the chloride-binding cotransport system in the ascending loop of Henle. In acute hypertensive states, administer furosemide intravenously (IV).

Labetalol (Trandate)

View full drug information

Labetalol blocks beta1-adrenergic, alpha-adrenergic, and beta2-adrenergic receptor sites, thereby decreasing BP.

Hydralazine

View full drug information

Hydralazine decreases systemic resistance through direct vasodilation of arterioles.

Nifedipine (Adalat, Procardia, Nifediac)

View full drug information

Nifedipine relaxes coronary smooth muscle and produces coronary vasodilation, which, in turn, improves myocardial oxygen delivery.

Nitroprusside (Nitropress)

View full drug information

Nitroprusside produces vasodilation and increases the inotropic activity of the heart. However, higher dosages may exacerbate myocardial ischemia by increasing the heart rate.

Class Summary

Administer antibiotics for 10 days to ensure eradication of streptococci, if the disease is believed to be poststreptococcal acute glomerulonephritis and risk of contamination is present.

Penicillin VK

View full drug information

Penicillin VK inhibits biosynthesis of cell wall mucopeptide and is bactericidal against sensitive organisms when adequate concentrations are reached. This agent is most effective during the stage of active multiplication.

Erythromycin base (E.E.S., EryPed, Ery-Tab, Erythrocin)

View full drug information

Erythromycin inhibits bacterial growth, possibly by blocking the dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest.

Questions

Avner ED, Davis ID. Acute poststreptococcal glomerulonephritis. Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Pa: Elsevier Science; 2004. 1740-41.
Rodríguez-Iturbe B, Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007 Jun. 71(11):1094-104. [QxMD MEDLINE Link].
Blyth CC, Robertson PW, Rosenberg AR. Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review. J Paediatr Child Health. 2007 Jun. 43(6):446-50. [QxMD MEDLINE Link].
Sanjad S, Tolaymat A, Whitworth J, Levin S. Acute glomerulonephritis in children: a review of 153 cases. South Med J. 1977 Oct. 70(10):1202-6. [QxMD MEDLINE Link].
Sagel I, Treser G, Ty A, et al. Occurrence and nature of glomerular lesions after group A streptococci infections in children. Ann Intern Med. 1973 Oct. 79(4):492-9. [QxMD MEDLINE Link].
Kimmelstiel P. The hump-a lesion of glomerulonephritis. Bull Pathol. 1965. 6:187.
Nissenson AR, Baraff LJ, Fine RN, Knutson DW. Poststreptococcal acute glomerulonephritis: fact and controversy. Ann Intern Med. 1979 Jul. 91(1):76-86. [QxMD MEDLINE Link].
Yoshizawa N, Yamakami K, Fujino M, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol. 2004 Jul. 15(7):1785-93. [QxMD MEDLINE Link].
Oda T, Yamakami K, Omasu F, et al. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2005 Jan. 16(1):247-54. [QxMD MEDLINE Link].
Poon-King R, Bannan J, Viteri A, Cu G, Zabriskie JB. Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med. 1993 Aug 1. 178(2):759-63. [QxMD MEDLINE Link]. [Full Text].
Parra G, Rodríguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. 1998 Aug. 54(2):509-17. [QxMD MEDLINE Link].
Cu GA, Mezzano S, Bannan JD, Zabriskie JB. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int. 1998 Sep. 54(3):819-26. [QxMD MEDLINE Link].
García R, Rubio L, Rodríguez-Iturbe B. Long-term prognosis of epidemic poststreptococcal glomerulonephritis in Maracaibo: follow-up studies 11-12 years after the acute episode. Clin Nephrol. 1981 Jun. 15(6):291-8. [QxMD MEDLINE Link].
Perlman LV, Herdman RC, Kleinman H, Vernier RL. Poststreptococcal glomerulonephritis. A ten-year follow-up of an epidemic. JAMA. 1965 Oct 4. 194(1):63-70. [QxMD MEDLINE Link].
Kandoth PW, Agarwal GJ, Dharnidharka VR. Acute renal failure in children requiring dialysis therapy. Indian Pediatr. 1994 Mar. 31(3):305-9. [QxMD MEDLINE Link].
Baldwin DS, Gluck MC, Schacht RG, Gallo G. The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med. 1974 Mar. 80(3):342-58. [QxMD MEDLINE Link].
World Health Organization. Countries. Available at http://www.who.int/countries/en/. Accessed: January 10, 2008.
Treser G, Semar M, McVicar M, Franklin M, Ty A, Sagel I, et al. Antigenic streptococcal components in acute glomerulonephritis. Science. 1969 Feb 14. 163(868):676-7. [QxMD MEDLINE Link].
Balter S, Benin A, Pinto SW, et al. Epidemic nephritis in Nova Serrana, Brazil. Lancet. 2000 May 20. 355(9217):1776-80. [QxMD MEDLINE Link].
Francis AJ, Nimmo GR, Efstratiou A, Galanis V, Nuttall N. Investigation of milk-borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia. J Infect. 1993 Nov. 27(3):317-23. [QxMD MEDLINE Link].
McIntosh RM, Kulvinskas C, Kaufman DB. Alteration of the chemical composition of human immunoglobulin G by Streptococcus pyogenes. J Med Microbiol. 1971 Nov. 4(4):535-8. [QxMD MEDLINE Link].
Gewurz H, Pickering RJ, Naff G, Snyderman R, Mergenhagen SE, Good RA. Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol. 1969. 36(6):592-8. [QxMD MEDLINE Link].
Wyatt RJ, Forristal J, West CD, Sugimoto S, Curd JG. Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol. 1988 Apr. 2(2):219-23. [QxMD MEDLINE Link].
Wyatt RJ, McAdams AJ, Forristal J, Snyder J, West CD. Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis. Kidney Int. 1979 Oct. 16(4):505-12. [QxMD MEDLINE Link].
Hisano S, Matsushita M, Fujita T, Takeshita M, Iwasaki H. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis. Pathol Int. 2007 Jun. 57(6):351-7. [QxMD MEDLINE Link].
Derrick CW, Reeves MS, Dillon HC Jr. Complement in overt and asymptomatic nephritis after skin infection. J Clin Invest. 1970 Jun. 49(6):1178-87. [QxMD MEDLINE Link]. [Full Text].
Levy M, Sich M, Pirotzky E, Habib R. Complement activation in acute glomerulonephritis in children. Int J Pediatr Nephrol. 1985 Jan-Mar. 6(1):17-24. [QxMD MEDLINE Link].
Sjöholm AG. Complement components and complement activation in acute poststreptococcal glomerulonephritis. Int Arch Allergy Appl Immunol. 1979. 58(3):274-84. [QxMD MEDLINE Link].
Strife CF, McAdams AJ, McEnery PT, Bove KE, West CD. Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology. J Pediatr. 1974 Jan. 84(1):29-38. [QxMD MEDLINE Link].
Tina LU, D'Albora JB, Antonovych TT, Bellanti JA, Calcagno PL. Acute glomerulonephritis associated with normal serum B1C-globulin. Am J Dis Child. 1968 Jan. 115(1):29-36. [QxMD MEDLINE Link].
West CD, McAdams AJ. Serum and glomerular IgG in poststreptococcal glomerulonephritis are correlated. Pediatr Nephrol. 1998 Jun. 12(5):392-6. [QxMD MEDLINE Link].
Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ. Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol. 2011 Feb. 26(2):165-80. [QxMD MEDLINE Link].
Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. 2008 Jul. 23(7):1101-6. [QxMD MEDLINE Link].
Longcope WT, O'Brien DP, McGuire J, Hansen OC, Denny ER. Relationship of acute infections to glomerular nephritis. J Clin Invest. 1927 Dec. 5(1):7-30. [QxMD MEDLINE Link]. [Full Text].
Dixon FJ, Feldman JD, Vazquez JJ. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1. 113:899-920. [QxMD MEDLINE Link]. [Full Text].
Wong W, Lennon DR, Crone S, Neutze JM, Reed PW. Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: epidemiology, clinical features and complications. J Paediatr Child Health. 2013 Oct. 49(10):850-5. [QxMD MEDLINE Link].
Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. 2009 Jan. 174(1):115-22. [QxMD MEDLINE Link]. [Full Text].
Lange K, Azadegan AA, Seligson G, Bovie RC, Majeed H. Asymptomatic poststreptococcal glomerulonephritis in relatives of patients with symptomatic glomerulonephritis. Diagnostic value of endostreptosin antibodies. Child Nephrol Urol. 1988-1989. 9(1-2):11-5. [QxMD MEDLINE Link].
Seligson G, Lange K, Majeed HA, Deol H, Cronin W, Bovie R. Significance of endostreptosin antibody titers in poststreptococcal glomerulonephritis. Clin Nephrol. 1985 Aug. 24(2):69-75. [QxMD MEDLINE Link].
Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008 Oct. 19(10):1855-64. [QxMD MEDLINE Link].
Greenbaum LA, Kerlin BA, Van Why S, Punzalan RC, Trost BA, Pan CG, et al. Concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia. Pediatr Nephrol. 2003 Dec. 18(12):1301-3. [QxMD MEDLINE Link].
Lau KK, Hastings MC, Delos Santos NM, Gaber LW, Ault BH. A child with post-streptococcal glomerulonephritis complicated by Coombs positive autoimmune haemolytic anemia. Internet J Nephro. 2007.
Haas M, Racusen LC, Bagnasco SM. IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features. Hum Pathol. 2008 Sep. 39(9):1309-16. [QxMD MEDLINE Link].
Pais PJ, Kump T, Greenbaum LA. Delay in diagnosis in poststreptococcal glomerulonephritis. J Pediatr. 2008 Oct. 153(4):560-4. [QxMD MEDLINE Link].
Ayoob RM, Schwaderer AL. Acute Kidney Injury and Atypical Features during Pediatric Poststreptococcal Glomerulonephritis. Int J Nephrol. 2016. 2016:5163065. [QxMD MEDLINE Link]. [Full Text].
Tokura T, Morita Y, Yorimitsu D, Horike H, Sasaki T, Kashihara N. Co-occurrence of poststreptococcal reactive arthritis and acute glomerulonephritis. Mod Rheumatol. 2008. 18(5):526-8. [QxMD MEDLINE Link].
Lewy JE, Salinas-Madrigal L, Herdson PB, Pirani CL, Metcoff J. Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis. Medicine (Baltimore). 1971 Nov. 50(6):453-501. [QxMD MEDLINE Link].
Dodge WF, Spargo BH, Travis LB, et al. Poststreptococcal glomerulonephritis. A prospective study in children. N Engl J Med. 1972 Feb 10. 286(6):273-8. [QxMD MEDLINE Link].
Sarkissian A, Papazian M, Azatian G, Arikiants N, Babloyan A, Leumann E. An epidemic of acute postinfectious glomerulonephritis in Armenia. Arch Dis Child. 1997 Oct. 77(4):342-4. [QxMD MEDLINE Link]. [Full Text].
Bingler MA, Ellis D, Moritz ML. Acute post-streptococcal glomerulonephritis in a 14-month-old boy: why is this uncommon?. Pediatr Nephrol. 2007 Mar. 22(3):448-50. [QxMD MEDLINE Link].
Li Volti S, Furnari ML, Garozzo R, Santangelo G, Mollica F. Acute post-streptococcal glomerulonephritis in an 8-month-old girl. Pediatr Nephrol. 1993 Dec. 7(6):737-8. [QxMD MEDLINE Link].
Burke EC, Titus JL. Poststreptococcal acute glomerulonephritis in children. Med Clin North Am. 1966 Jul. 50(4):1141-58. [QxMD MEDLINE Link].
Travis LB, Dodge WF, Beathard GA, Spargo BH, Lorentz WB, Carvajal HF, et al. Acute glomerulonephritis in children. A review of the natural history with emphasis on prognosis. Clin Nephrol. 1973 May-Jun. 1(3):169-81. [QxMD MEDLINE Link].
Rodríguez-Iturbe B. Epidemic poststreptococcal glomerulonephritis. Kidney Int. 1984 Jan. 25(1):129-36. [QxMD MEDLINE Link].
Bouhard BH, Travis LB. Acute postinfectious glomerulonephritis. Eldeman CM, Ed. Pediatric Kidney Disease. 2nd ed. Boston, Mass: Little, Brown and Company; 1992. 1199-1221.
Choyke PL, Bluth EI, Bush WH Jr, et al, and the Expert Panel on Urologic Imaging. ACR Appropriateness Criteria: hematuria. [online publication]. Reston,Va: American College of Radiology (ACR); 2005.
Jennings RB, Earle DP. Post-streptococcal glomerulo-nephritis: histopathologic and clinical studies of the acute, subsiding acute and early chronic latent phases. J Clin Invest. 1961 Aug. 40:1525-95. [QxMD MEDLINE Link]. [Full Text].
Anand SK, Trygstad CW, Sharma HM, Northway JD. Extracapillary proliferative glomerulonephritis in children. Pediatrics. 1975 Sep. 56(3):434-42. [QxMD MEDLINE Link].
Roy S 3rd, Murphy WM, Arant BS Jr. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr. 1981 Mar. 98(3):403-10. [QxMD MEDLINE Link].
Wong W, Morris MC, Zwi J. Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children. Pediatr Nephrol. 2009 May. 24(5):1021-6. [QxMD MEDLINE Link].
Fish AJ, Herdman RC, Michael AF, Pickering RJ, Good RA. Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. II. Correlative study of light, immunofluorescent and electron microscopic findings. Am J Med. 1970 Jan. 48(1):28-39. [QxMD MEDLINE Link].
McCluskey RT, Vassalli P, Gallo G, Baldwin DS. An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med. 1966 Mar 31. 274(13):695-701. [QxMD MEDLINE Link].
Yoshizawa N. Acute glomerulonephritis. Intern Med. 2000 Sep. 39(9):687-94. [QxMD MEDLINE Link].
Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol. 2005 Jul. 12(7):833-6. [QxMD MEDLINE Link]. [Full Text].
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005 Nov. 5(11):685-94. [QxMD MEDLINE Link].
Shank JC, Powell TA. A five-year experience with throat cultures. J Fam Pract. 1984 Jun. 18(6):857-63. [QxMD MEDLINE Link].
Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981. 1(3):239-46. [QxMD MEDLINE Link].
McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan 13. 158(1):75-83. [QxMD MEDLINE Link]. [Full Text].
Edmonson MB, Farwell KR. Relationship between the clinical likelihood of group a streptococcal pharyngitis and the sensitivity of a rapid antigen-detection test in a pediatric practice. Pediatrics. 2005 Feb. 115(2):280-5. [QxMD MEDLINE Link].
American Academy of Pediatrics, Committee in Infectious Diseases. Group A streptococcal infections. The Red Book. Elk Grove Village, Ill: American Academy of Pediatrics; 2000. 526-92.
Acute Poststreptococcal Glomerulonephritis: The Most Common Acute Glomerulonephritis. Pediatrics in Review. 2015. 36:3-13. [Full Text].
Hunt EAK, Somers MJG. Infection-Related Glomerulonephritis. Pediatr Clin North Am. 2019 Feb. 66 (1):59-72. [QxMD MEDLINE Link].
Demircioglu Kılıc B, Akbalık Kara M, Buyukcelik M, Balat A. Pediatric post-streptococcal glomerulonephritis: Clinical and laboratory data. Pediatr Int. 2018 May 5. [QxMD MEDLINE Link].

Media Gallery

Schematic representation of proposed mechanisms involved in the development of acute poststreptococcal glomerulonephritis (APSGN).MES: mesangial cell; END: endothelial cell; PMN: polymorphonuclear cell; MΦ: macrophage; T: T lymphocyte; GMB: glomerular basement membrane; C: complement; Anti-NAPlr-Ab: Anti-NAPlr-antibody. Courtesy of open access article, "The Role of Nephritis-Associated Plasmin Receptor (NAPlr) in Glomerulonephritis Associated with Streptococcal Infection." Oda T, Yoshizawa N, Yamakami K, et al. Journal of Biomedicine and Biotechnology, 2012; doi: 10.1155/417675.

of 1

Sections Acute Poststreptococcal Glomerulonephritis
Overview
Presentation
DDx
Workup
Treatment
Medication
Questions & Answers
References

Acute Poststreptococcal Glomerulonephritis Medication

Medication Summary

Antihypertensives

Class Summary

Amlodipine (Norvasc)

Amlodipine (Norvasc)

Furosemide (Lasix)

Furosemide (Lasix)

Labetalol (Trandate)

Labetalol (Trandate)

Hydralazine

Hydralazine

Nifedipine (Adalat, Procardia, Nifediac)

Nifedipine (Adalat, Procardia, Nifediac)

Nitroprusside (Nitropress)

Nitroprusside (Nitropress)

Antibiotics

Class Summary

Penicillin VK

Penicillin VK

Erythromycin base (E.E.S., EryPed, Ery-Tab, Erythrocin)

Erythromycin base (E.E.S., EryPed, Ery-Tab, Erythrocin)

Acute Poststreptococcal Glomerulonephritis Medication

Medication Summary

Antihypertensives

Class Summary

Amlodipine (Norvasc)

Furosemide (Lasix)

Labetalol (Trandate)

Hydralazine

Nifedipine (Adalat, Procardia, Nifediac)

Nitroprusside (Nitropress)

Antibiotics

Class Summary

Penicillin VK

Erythromycin base (E.E.S., EryPed, Ery-Tab, Erythrocin)

References

Tables

Contributor Information and Disclosures

What would you like to print?